Last reviewed · How we verify

Levobupivacaine without epinephrine

Pontificia Universidad Catolica de Chile · FDA-approved active Small molecule

Levobupivacaine without epinephrine is a Local anesthetic (amide) Small molecule drug developed by Pontificia Universidad Catolica de Chile. It is currently FDA-approved for Local and regional anesthesia for surgical procedures, Infiltration anesthesia, Nerve blocks.

Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials. Used for Local and regional anesthesia for surgical procedures, Infiltration anesthesia, Nerve blocks.

At a glance

Generic nameLevobupivacaine without epinephrine
SponsorPontificia Universidad Catolica de Chile
Drug classLocal anesthetic (amide)
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Levobupivacaine is the S-enantiomer of bupivacaine, a long-acting amide local anesthetic. It reversibly binds to and blocks voltage-gated sodium channels on the inner surface of nerve cell membranes, preventing depolarization and transmission of nerve impulses. The absence of epinephrine means this formulation lacks vasoconstrictive properties and relies solely on the anesthetic's intrinsic duration of action.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Levobupivacaine without epinephrine

What is Levobupivacaine without epinephrine?

Levobupivacaine without epinephrine is a Local anesthetic (amide) drug developed by Pontificia Universidad Catolica de Chile, indicated for Local and regional anesthesia for surgical procedures, Infiltration anesthesia, Nerve blocks.

How does Levobupivacaine without epinephrine work?

Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

What is Levobupivacaine without epinephrine used for?

Levobupivacaine without epinephrine is indicated for Local and regional anesthesia for surgical procedures, Infiltration anesthesia, Nerve blocks, Epidural anesthesia.

Who makes Levobupivacaine without epinephrine?

Levobupivacaine without epinephrine is developed and marketed by Pontificia Universidad Catolica de Chile (see full Pontificia Universidad Catolica de Chile pipeline at /company/pontificia-universidad-catolica-de-chile).

What drug class is Levobupivacaine without epinephrine in?

Levobupivacaine without epinephrine belongs to the Local anesthetic (amide) class. See all Local anesthetic (amide) drugs at /class/local-anesthetic-amide.

What development phase is Levobupivacaine without epinephrine in?

Levobupivacaine without epinephrine is FDA-approved (marketed).

What are the side effects of Levobupivacaine without epinephrine?

Common side effects of Levobupivacaine without epinephrine include Injection site reactions (pain, erythema), Transient neurological symptoms, Hypotension, Bradycardia, Systemic toxicity (CNS and cardiac effects at high doses).

What does Levobupivacaine without epinephrine target?

Levobupivacaine without epinephrine targets Voltage-gated sodium channels and is a Local anesthetic (amide).

Related